OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bile acid-mediated signaling in cholestatic liver diseases
Jing Zeng, Jian‐Gao Fan, Huiping Zhou
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Jing Zeng, Jian‐Gao Fan, Huiping Zhou
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 6
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 6
Mechanistic studies on the alleviation of ANIT-induced cholestatic liver injury by Polygala fallax Hemsl. polysaccharides
Guoqiang Guan, Houkang Cao, Zixuan Tang, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118108-118108
Open Access | Times Cited: 5
Guoqiang Guan, Houkang Cao, Zixuan Tang, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118108-118108
Open Access | Times Cited: 5
Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in Cholestasis
Ludovica Ceci, Eugenio Gaudio, Lindsey Kennedy
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 4, pp. 553-565
Open Access | Times Cited: 4
Ludovica Ceci, Eugenio Gaudio, Lindsey Kennedy
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 4, pp. 553-565
Open Access | Times Cited: 4
Livogrit Mitigates ANIT-Induced Cholestasis-Like Symptoms in an In Vivo model by Curbing Hepatic Inflammation and Regulating BAX, TGF-β, MMP-9 and α-SMA Gene Expression
Acharya Balkrishna, Ritu Paliwal, Surjeet Singh, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e41855-e41855
Open Access
Acharya Balkrishna, Ritu Paliwal, Surjeet Singh, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e41855-e41855
Open Access
Immunobiology of bile and cholangiocytes
Li Yang, Patrick S.C. Leung, Weici Zhang, et al.
Journal of Autoimmunity (2025) Vol. 151, pp. 103376-103376
Closed Access
Li Yang, Patrick S.C. Leung, Weici Zhang, et al.
Journal of Autoimmunity (2025) Vol. 151, pp. 103376-103376
Closed Access
Patented Farnesoid X receptor modulators: a review (2019 – present)
Antimo Gioiello, Emiliano Rosatelli, Bruno Cerra
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 7, pp. 547-564
Closed Access | Times Cited: 3
Antimo Gioiello, Emiliano Rosatelli, Bruno Cerra
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 7, pp. 547-564
Closed Access | Times Cited: 3
Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR
Ümran Ay, Martin Leníček, Raphael S. Haider, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 3
Ümran Ay, Martin Leníček, Raphael S. Haider, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 3
The gut microbiota-bile acid axis in cholestatic liver disease
Dayan Sun, Chuanping Xie, Yong Zhao, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Dayan Sun, Chuanping Xie, Yong Zhao, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Changes in bile acid subtypes and improvements in lipid metabolism and atherosclerotic cardiovascular disease risk: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial
Yoriko Heianza, Qiaochu Xue, Jennifer Rood, et al.
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 5, pp. 1293-1300
Open Access | Times Cited: 2
Yoriko Heianza, Qiaochu Xue, Jennifer Rood, et al.
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 5, pp. 1293-1300
Open Access | Times Cited: 2
Goat Milk Improves Glucose Metabolism in Type 2 Diabetic Mice and Protects Pancreatic β‐Cell Functions
Xiaoying Chen, Zhifei Zhang, Huiming Niu, et al.
Molecular Nutrition & Food Research (2023) Vol. 68, Iss. 1
Closed Access | Times Cited: 6
Xiaoying Chen, Zhifei Zhang, Huiming Niu, et al.
Molecular Nutrition & Food Research (2023) Vol. 68, Iss. 1
Closed Access | Times Cited: 6
Quantitative proteomics reveals the protective effects of Yinchenzhufu decoction against cholestatic liver fibrosis in mice by inhibiting the PDGFRβ/PI3K/AKT pathway
Qian Meng, Hongwen Zhu, Yuanyuan Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Qian Meng, Hongwen Zhu, Yuanyuan Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Microbiome composition recovery after liver transplantation correlates with initial liver disease severity and antibiotics treatment
Sara Vega-Abellaneda, Cristina Dopazo, Francisca Yañez, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 9, pp. 1623-1633
Closed Access | Times Cited: 1
Sara Vega-Abellaneda, Cristina Dopazo, Francisca Yañez, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 9, pp. 1623-1633
Closed Access | Times Cited: 1
Molecular insights into experimental models and therapeutics for cholestasis
Wenwen Zhang, Hefei Wu, Shiman Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116594-116594
Open Access | Times Cited: 1
Wenwen Zhang, Hefei Wu, Shiman Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116594-116594
Open Access | Times Cited: 1
Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury
Yun Zhou, Meijie Li, Yutong Cao, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112799-112799
Closed Access | Times Cited: 1
Yun Zhou, Meijie Li, Yutong Cao, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112799-112799
Closed Access | Times Cited: 1
Arachidonic acid enhances hepatocyte bile acid uptake and alleviates cholestatic liver disease by upregulating OATP1 expression
Yanlu Ma, Chen Zou, Yilan Yang, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9916-9927
Closed Access | Times Cited: 1
Yanlu Ma, Chen Zou, Yilan Yang, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9916-9927
Closed Access | Times Cited: 1
Apigenin as an emerging hepatoprotective agent: current status and future perspectives
Cheng Wang, Xiaoli Feng, Wen Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Cheng Wang, Xiaoli Feng, Wen Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Vanessa Goyon, Aurèle Besse‐Patin, Rodolfo Zunino, et al.
EMBO Reports (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 3
Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies
Tianhao Zhou, AbdiGhani Ismail, Heather Francis
Cells (2023) Vol. 12, Iss. 23, pp. 2725-2725
Open Access | Times Cited: 3
Tianhao Zhou, AbdiGhani Ismail, Heather Francis
Cells (2023) Vol. 12, Iss. 23, pp. 2725-2725
Open Access | Times Cited: 3
Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells
Yangfeng Lv, Chuan-Sheng Xie, Zhixing Liu, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116121-116121
Closed Access
Yangfeng Lv, Chuan-Sheng Xie, Zhixing Liu, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116121-116121
Closed Access
Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders
Bandar D. Alrehaili
Saudi Journal of Gastroenterology (2024) Vol. 30, Iss. 5, pp. 283-293
Open Access
Bandar D. Alrehaili
Saudi Journal of Gastroenterology (2024) Vol. 30, Iss. 5, pp. 283-293
Open Access
Gubra Amylin‐NASH Diet Induced Nonalcoholic Fatty Liver Disease Associated with Histological Damage, Oxidative Stress, Immune Disorders, Gut Microbiota, and Its Metabolic Dysbiosis in Colon
Zhimin Zhang, Xinyi Qin, Yi Tao, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 15
Closed Access
Zhimin Zhang, Xinyi Qin, Yi Tao, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 15
Closed Access
STING-mediated IL-6 Inhibits OATP1B1 Expression via the TCF4 Signaling Pathway in Cholestasis
Yan Guo, Hongjia Zhang, Nan Zhao, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Yan Guo, Hongjia Zhang, Nan Zhao, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Fecal deoxycholic acid associates with diet, intestinal microbes and total bilirubin in primary sclerosing cholangitis
Connie Chan, Mateus Lacerda Pereira Lemos, Peter Finnegan, et al.
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101188-101188
Open Access
Connie Chan, Mateus Lacerda Pereira Lemos, Peter Finnegan, et al.
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101188-101188
Open Access
Evaluation of Protein Impurities in Ademetionine 1,4-Butanedisulfonate
Yangrui Zhang, Jiang Xintong, Fengting Ou, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 253, pp. 116560-116560
Closed Access
Yangrui Zhang, Jiang Xintong, Fengting Ou, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 253, pp. 116560-116560
Closed Access
